|
NRBF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.212460E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.156390E-02 |
| Normal-vs-Stage2 |
3.901000E-01 |
| Normal-vs-Stage3 |
2.549400E-01 |
| Normal-vs-Stage4 |
4.096200E-02 |
| Stage1-vs-Stage2 |
4.059600E-01 |
| Stage1-vs-Stage3 |
3.002200E-01 |
| Stage1-vs-Stage4 |
5.919800E-01 |
| Stage2-vs-Stage3 |
9.605800E-01 |
| Stage2-vs-Stage4 |
2.784800E-01 |
| Stage3-vs-Stage4 |
2.408600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.004150E-02 |
| Normal-vs-AfricanAmerican |
3.549200E-01 |
| Normal-vs-Asian |
1.924840E-01 |
| Caucasian-vs-AfricanAmerican |
5.779800E-01 |
| Caucasian-vs-Asian |
8.125600E-01 |
| AfricanAmerican-vs-Asian |
6.634600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.988100E-02 |
| Normal-vs-Female |
1.690090E-02 |
| Male-vs-Female |
6.770200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.616000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.016100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.596300E-02 |
| Normal-vs-Age(81-100Yrs) |
5.616600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.583400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.954800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.825000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.163000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.983200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.341000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.297400E-01 |
| Normal-vs-Grade 2 |
3.692000E-02 |
| Normal-vs-Grade 3 |
1.292160E-01 |
| Normal-vs-Grade 4 |
3.843900E-03 |
| Grade 1-vs-Grade 2 |
8.677400E-01 |
| Grade 1-vs-Grade 3 |
9.165400E-01 |
| Grade 1-vs-Grade 4 |
1.596810E-01 |
| Grade 2-vs-Grade 3 |
6.263800E-01 |
| Grade 2-vs-Grade 4 |
8.371900E-02 |
| Grade 3-vs-Grade 4 |
4.861700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.449580E-01 |
| Normal-vs-ccB subtype |
5.243600E-04 |
| ccA subtype-vs-ccB subtype |
1.134160E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.313510E-02 |
| Normal-vs-N1 |
1.770830E-01 |
| N0-vs-N1 |
4.588000E-01 |
|
|
